Literature DB >> 25809571

Leptin upregulation in advanced multiple system atrophy with hypocholesterolemia and unexpected fat accumulation.

Utako Nagaoka1, Toshio Shimizu, Toshiki Uchihara.   

Abstract

Advanced multiple system atrophy (MSA) patients exhibit malnutrition with hypocholesterolemia and hypoalbuminemia, similar to patients with other neurodegenerative disorders, but also display unexpected fat accumulation. To understand this paradox, we herein examined the relationship between fat accumulation, measured by triceps skinfold thickness (TSF), and plasma leptin in 29 MSA patients at three clinical stages: activities of daily living (ADL) 1: ambulatory with/without wheelchair; ADL2: bedridden/communicable; and ADL3: bedridden/non-communicable. TSF and leptin were higher while cholesterol and albumin were lower in advanced stage ADL3 than in ADL1 or ADL2. Although a correlation was observed between leptin and TSF, a stepwise regression analysis identified the first significant positive predictor of leptin as the duration of autonomic symptoms (p < 0.005) rather than TSF. Leptin/TSF strongly correlated with the duration of autonomic symptoms (p < 0.001). These results implicate leptin resistance through autonomic dysfunction in the paradoxical fat accumulation observed in patients with advanced MSA, but not to be seen in the cholesterol metabolism.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 25809571     DOI: 10.1007/s10072-015-2189-y

Source DB:  PubMed          Journal:  Neurol Sci        ISSN: 1590-1874            Impact factor:   3.307


  23 in total

1.  Effect of statin therapy on leptin levels in patients with coronary heart disease.

Authors:  Yan-Ming Sun; Jia Li; Ying Luan; Lan-Feng Wang
Journal:  Peptides       Date:  2010-03-23       Impact factor: 3.750

2.  Clinical features and natural history of multiple system atrophy. An analysis of 100 cases.

Authors:  G K Wenning; Y Ben Shlomo; M Magalhães; S E Daniel; N P Quinn
Journal:  Brain       Date:  1994-08       Impact factor: 13.501

3.  The use of upper extremity anthropometrics in the clinical assessment of patients with amyotrophic lateral sclerosis.

Authors:  E J Kasarskis; S Berryman; T English; J Nyland; J G Vanderleest; A Schneider; R Berger; C McClain
Journal:  Muscle Nerve       Date:  1997-03       Impact factor: 3.217

4.  Differential involvement of hypothalamic vasopressin neurons in multiple system atrophy.

Authors:  Eduardo E Benarroch; Ann M Schmeichel; Paola Sandroni; Phillip A Low; Joseph E Parisi
Journal:  Brain       Date:  2006-05-02       Impact factor: 13.501

Review 5.  Sarcopenic obesity: definition, cause and consequences.

Authors:  Sari Stenholm; Tamara B Harris; Taina Rantanen; Marjolein Visser; Stephen B Kritchevsky; Luigi Ferrucci
Journal:  Curr Opin Clin Nutr Metab Care       Date:  2008-11       Impact factor: 4.294

Review 6.  The procognitive effects of leptin in the brain and their clinical implications.

Authors:  G Paz-Filho; M-L Wong; J Licinio
Journal:  Int J Clin Pract       Date:  2010-12       Impact factor: 2.503

7.  Second consensus statement on the diagnosis of multiple system atrophy.

Authors:  S Gilman; G K Wenning; P A Low; D J Brooks; C J Mathias; J Q Trojanowski; N W Wood; C Colosimo; A Dürr; C J Fowler; H Kaufmann; T Klockgether; A Lees; W Poewe; N Quinn; T Revesz; D Robertson; P Sandroni; K Seppi; M Vidailhet
Journal:  Neurology       Date:  2008-08-26       Impact factor: 9.910

8.  Leptin in sarcopenic visceral obesity: possible link between adipocytes and myocytes.

Authors:  Katsuhiko Kohara; Masayuki Ochi; Yasuharu Tabara; Tokihisa Nagai; Michiya Igase; Tetsuro Miki
Journal:  PLoS One       Date:  2011-09-09       Impact factor: 3.240

Review 9.  Multiple system atrophy: a primary oligodendrogliopathy.

Authors:  Gregor K Wenning; Nadia Stefanova; Kurt A Jellinger; Werner Poewe; Michael G Schlossmacher
Journal:  Ann Neurol       Date:  2008-09       Impact factor: 10.422

10.  Sarcopenic obesity and endocrinal adaptation with age.

Authors:  Kunihiro Sakuma; Akihiko Yamaguchi
Journal:  Int J Endocrinol       Date:  2013-04-11       Impact factor: 3.257

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.